Managed Healthcare Executive3h
FDA Approves NDA for Gilead's new HIV Prevention Shot
Lenacapavir is a twice-yearly injectable medication designed to be used as pre-exposure prophylaxis (PrEP). The FDA is giving ...
FiercePharma8h
Bavarian Nordic catches up to rival Valneva with broad chikungunya vaccine approval from FDA
Two years on, Bavarian Nordic’s $380 million vaccine M&A move appears to be paying off. | Valneva may have won the ...
Gilead Gets FDA Priority Review of Twice-Yearly Shot to Prevent HIV
Gilead Sciences has won Food and Drug Administration priority review for its proposed lenacapavir twice-yearly shot to prevent HIV. Gilead on Tuesday said an FDA green light would make lenacapavir the ...
Chimerix’s NDA for dordaviprone accepted by FDA
Chimerix (CMRX) announced the FDA has accepted its New Drug Application, or NDA, seeking accelerated approval for dordaviprone as a treatment ...
The New Times on MSN1d
How Rwanda’s new bill seeks to protect e-commerce buyers
The government has introduced a bill aimed at addressing concerns resulting from the growing trends in e-commerce, including fraudulent practices, by strengthening consumer protection and promoting ...
Business and Financial Times on MSN5d
FDA leads seven African regulators to foster trust and accelerate access to medicines
The Ghana Food and Drugs Authority (FDA) has spearheaded a joint initiative with National Regulatory Authorities (NRAs) in ...